Skip to main content

Correction: Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim results

The Original Article was published on 18 November 2022

Correction: J Headache Pain 23, 142 (2022)

https://doi.org/10.1186/s10194-022-01515-8

Following publication of the original article [1], the author group has identified an error in Fig. 1. The correct figure is given below.

Fig. 1
figure 1

Study design and visit schedule. mo: month; V: visit

The original article [1] has been corrected.

Reference

  1. Gantenbein AR, Agosti R, Kamm CP et al (2022) Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim results. J Headache Pain 23:142. https://doi.org/10.1186/s10194-022-01515-8

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andreas R. Gantenbein.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Gantenbein, A.R., Agosti, R., Kamm, C.P. et al. Correction: Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim results. J Headache Pain 23, 161 (2022). https://doi.org/10.1186/s10194-022-01530-9

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s10194-022-01530-9